Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeting systemic inflammation to improve endothelial function in obesity
2009-016855-23Phase 4Terminated
- Sponsor
- University of Leeds
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of pentoxifylline in obesity, sponsored by University of Leeds. Primary endpoint: Flow-mediated dilatation (FMD) of the brachial artery. Started Jul 2010; status: terminated.
02
Drugs
pentoxifylline
03
Conditions
obesity
Beyond the preview
Go deeper on 2009-016855-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016855-23.